PHG
Koninklijke Philips N.V.
NYSE · Healthcare · Medical - Devices · NL
$25.89
−0.61%Income statement
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | |||||
| Total Revenue | 17.7B | 17.8B | 18.0B | 18.2B | 17.8B |
| Cost of Revenue | 9.6B | 9.8B | 10.2B | 10.7B | 10.6B |
| Gross Profit | 8.1B | 8.1B | 7.8B | 7.4B | 7.2B |
| Operating Expenses | |||||
| R&D Expense | 1.7B | 1.7B | 1.7B | 1.9B | 2.1B |
| SG&A Expense | 4.9B | 5.0B | 5.1B | 5.1B | 5.3B |
| General & Admin Expense | 643.0M | 628.0M | 582.0M | 608.0M | 671.0M |
| Selling & Marketing Expense | 4.2B | 4.3B | 4.5B | 4.5B | 4.6B |
| Other Expenses | (201.0M) | (36.0M) | 429.0M | 541.0M | 1.3B |
| Total Operating Expenses | 6.4B | 6.6B | 7.2B | 7.6B | 8.7B |
| Cost and Expenses | 15.9B | 16.4B | 17.5B | 18.3B | 19.4B |
| Operating Income (EBIT) | 1.7B | 1.4B | 529.0M | (115.0M) | (1.5B) |
| Non-Operating | |||||
| Interest Income | 126.6M | 108.5M | 79.0M | 46.0M | 25.0M |
| Interest Expense | 363.8M | 332.3M | 337.0M | 306.0M | 244.0M |
| Net Interest Income | (237.3M) | (223.8M) | (257.0M) | (260.0M) | (219.0M) |
| Other Non-Op Income/Expense | (244.0M) | (242.0M) | (406.0M) | (412.0M) | (202.0M) |
| Non-Operating Income (excl Interest) | (99.0M) | (90.3M) | 69.0M | 105.0M | (42.0M) |
| EBT (Pre-Tax Income) | 1.5B | 1.2B | 123.0M | (527.0M) | (1.7B) |
| Income Tax Expense | 364.0M | 282.0M | 963.0M | (73.0M) | (113.0M) |
| Bottom Line | |||||
| Net Income | 1.1B | 895.0M | (702.0M) | (466.0M) | (1.6B) |
| Earnings from Cont. Ops | 1.1B | 900.0M | (840.0M) | (454.0M) | (1.6B) |
| Earnings from Discont. Ops | 3.0M | (4.0M) | 142.0M | (10.0M) | 13.0M |
| Bottom Line Net Income | 1.1B | 899.0M | (702.0M) | (466.0M) | (1.6B) |
| Per Share | |||||
| Basic EPS | $1.16 | $0.95 | ($0.75) | ($0.49) | ($1.68) |
| Diluted EPS | $1.16 | $0.93 | ($0.75) | ($0.49) | ($1.68) |
| Revenue Per Share | $18.49 | $18.53 | $19.31 | $19.15 | $18.72 |
| Shares | |||||
| Basic Shares Outstanding | 955.6M | 962.4M | 933.4M | 948.8M | 952.5M |
| Diluted Shares Outstanding | 968.6M | 962.5M | 933.4M | 948.8M | 952.5M |
| Profitability Metrics | |||||
| EBITDA | 3.0B | 2.6B | 1.8B | 1.0B | 115.0M |
| D&A | 1.2B | 1.1B | 1.4B | 1.3B | 1.6B |
| EBIT | 1.8B | 1.5B | 460.0M | (220.0M) | (1.5B) |
As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Jun 1, 2026